dm+d

419143009

Articles

Safety in Lactation: Drugs for the relief of soft-tissue inflammation and topical pain relief

28 October 2020Topical formulations of non-steroidal anti-inflammatories (NSAIDS) and capsaicin produce low systemic levels in the mother. Although there is no direct evidence, subsequent milk levels are…

Safety in Lactation: Non-steroidal anti-inflammatory drugs

23 September 2020There is very limited information on the use of NSAIDs during breastfeeding; ibuprofen and diclofenac are the preferred choices due to their extensive safe use…

Safety in Lactation: Ocular peri-operative preparations

23 September 2020Drugs in this group have varying uses immediately before, during or following eye surgery. Their use is, therefore, usually on a relatively short-term basis. In…

Which medicines are considered safe for use in the acute porphyrias?

29 May 2020This updated Medicines Q&A presents a table of the medicines considered safe for use in the acute porphyrias. Inclusion of a drug does not guarantee…

Do NSAIDs increase the risk of severe skin reactions in children with chickenpox?

1 October 2019This Q&A evaluates the limited published evidence investigating an association between Non-steroidal anti-inflammatory drugs (NSAIDs) and severe skin reactions in children with chickenpox.
Search Articles

Medicine Compliance Aid Stability

Voltarol RetardNovartis Pharmaceuticals UK Ltd

Novartis Pharmaceuticals UK Ltd
Voltarol Retard
Tablets 100mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Protect from light. Protect from moisture
12 August 2015

Diclomax RetardGalen Ltd

Galen Ltd
Diclomax Retard
Capsules 100mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Protect from light and moisture.
12 August 2015

genericDexcel Pharma Ltd

Dexcel Pharma Ltd
generic
Tablets 100mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Protect from light. Protect from moisture
12 August 2015

Voltarol 75mg SRNovartis Pharmaceuticals UK Ltd

Novartis Pharmaceuticals UK Ltd
Voltarol 75mg SR
Tablets 75mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Protect from light. Protect from moisture
12 August 2015

VoltarolNovartis Pharmaceuticals UK Ltd

Novartis Pharmaceuticals UK Ltd
Voltarol
Tablets dispersible 50mg
R1 · Red 1Stability data indicates that the drug is not suitable for CAs.
Unsuitable
Dispersible tablet
12 August 2015

VoltarolNovartis Pharmaceuticals UK Ltd

Novartis Pharmaceuticals UK Ltd
Voltarol
Tablets 25mg, 50mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Protect from light. Protect from moisture
12 August 2015

genericTeva UK Ltd

Teva UK Ltd
generic
Tablets 25mg, 50mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from light
12 August 2015

genericSandoz Ltd

Sandoz Ltd
generic
Tablets 75mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Protect from light. Protect from moisture
12 August 2015

MotifeneDaiichi Sankyo UK Ltd

Daiichi Sankyo UK Ltd
Motifene
Capsules 75mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Protect from light. Protect from moisture.
12 August 2015

Diclomax SRGalen Ltd

Galen Ltd
Diclomax SR
Capsules 75mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Protect from light. Protect from moisture.
12 August 2015

RhumalganSandoz Ltd

Sandoz Ltd
Rhumalgan
Capsules 100mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Protect from light and moisture.
14 September 2015

RhumalganSandoz Ltd

Sandoz Ltd
Rhumalgan
Capsules 75mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Protect from light and moisture.
14 September 2015

Lactation Safety Information

For oral/ rectal/ parenteral use

For oral/ rectal/ parenteral use
Yes
Extensive experience of safe use in breastfeeding
Limited published evidence of safety
No adverse effects reported in breastfed infants
Small amounts in breast milk
29 July 2020

Topical

Topical
Yes
Negligible milk levels anticipated as systemic absorption from topical formulations is low
Follow normal precautions for topical medicines (see summary)
29 July 2020

For ophthalmic use

For ophthalmic use
Yes
29 July 2020

For actinic keratitis

For actinic keratitis
Yes
Negligible milk levels anticipated as systemic absorption from topical formulations is low
Avoid contact of the breastfeeding infant with treated areas
30 October 2020